ABBV: A Safe 4.7% Yield in Biopharma
January 20, 2021 at 19:19 PM EST
Even with the slightly lower free cash flow total in 2019, AbbVie had more than enough to afford the $6.4 billion in dividends that it paid.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |